Document is current
Any future updates will be listed below
-
Authors
Burse, Natasha Renee
Lehman, Erik
Chinchilli, Vernon M.
Cuffee, Yendelela L.
Wray, Linda A.
Lengerich, Eugene J.
Schmitz, Kathryn H.
-
Funding
Funding for this research was provided by:
National Cancer Institute (F99CA253762, U54155850)
- License Information
-
More Information
Article History
Received: 20 April 2023
Accepted: 8 January 2024
First Online: 22 January 2024
Declarations
:
: The authors declare no competing interests.
: The WISER Survivor trial was approved by the IRB of the University of Pennsylvania. The current study was approved by the IRB of the Pennsylvania State University College of Medicine (STUDY00014712).
: Not applicable.
: Not applicable.
: The SAS code will not be made available.
: The study participants provided signed informed consent and a written clearance from their doctors to participate in the WISER Survivor trial. Informed consent was not obtained in the current study because the research involves no more than minimal risk to subjects and no procedures for which written consent is normally required outside of the research context.
: The authors declare that they have no conflict of interest.
: Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number F99CA253762 and U54155850. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
